Abstract
Sample size is an important interest of researchers in laboratory and clinical settings. The number of cases to be investigated profoundly affects the cost and duration of a study. Sample size is estimated to achieve a certain statistical power and a careful power and sample size analysis can predetermine the success of a study or experiment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lehman, E. L. (1959) Testing Statistical Hypotheses. John Wiley & Sons, New York.
Lee, S. E. and Zelen, M. (2000) Clinical trials and sample size considerations: another perspective. Statist. Sci. 15, 95–100.
Altman, D. G. (1994) The scandal of poor medical research. Br. Med. J. 308,283–284.
Freiman, J. A., Chalmers, T. C, Smith, H., Jr., and Kuebler, R. R. (1978) The importance of beta, the Type II error and sample size in the design and interpretation of the randomized control trial. N. Engl. J. Med. 20, 690–694.
Cohen, J. (1987) Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Lawrence Erlbaum, Hillsdale, NJ.
SAS, Statistical Analysis System, SAS Institute Inc., SAS Campus Drive, Cary, NC 27513.
SPSS, Statistical Package, for the Social Sciences, 233 South Wacker Drive, Chicago, IL 60606.
Beahrs, O. H., Henson, D. E., Hutter, R. V. P., Kennedy. (ed.) (1993) Handbook for Staging of Cancer. J. B. Lippincott, Philadelphia.
Kraemer, H. C. and Thiemann, S. (1987) How Many Subjects? Statistical Power Analysis in Research. SAGE, Newbury Park, CA, pp. 81–83.
Cohen, J. (1983) The cost of dichotomization. Appl. Psychol. Meas. 78, 240–253.
Goldsmith, L. J. (1995) Pros and cons of cutpoints, in Proceedings of the Biometrics Section, Papers presented at the Annual Meeting of the American Statistical Association, Orlando, FL, August 13–17, 1995, pp. 272–276.
Hughes, M D. (1999) The use and evaluation of suggogate endpoints in clinical trails, in 54th Deming Conference on Applied Statistics, Atlantic City, NJ, December 8, 1999.
Lefkopoulou, M. and Zelen, M. (1995) Intermediate clinical events, surrogate markers and survival. Lifetime Data Anal. 1, 73–86.
Topol, E. J., Califf, R. M., VandeWerf, F., Simoons, M., et al. (1997) Perspectives on large-scale cardiovascular clinical trials for the new millennium. Circulation 95, 1072–1082.
Cohen, J. (1990) Things I have learned (so far). Am. Psychol. 45, 1304.
Beck, A. T. and Steer, R. A. (1993) Beck Depression Inventory: Manual. Psychological Corporation, San Antonio, TX.
Venter, A. and Maxwell, S. E. (1999) Maximizing power in randomized designs when N is small, in Statistical Strategies for Small Sample Research (Hoyle, R. H., ed.) SAGE, Thousand Oaks, CA, pp. 31–58.
Muller, K. E., LaVange, L. M., Ramey, S. L., and Ramey, C. T. (1992) Power calculations for general linear multivariate models including repeated measures applications. J. Am. Statist. Assoc. 87, 1209–1226.
Shuster, J. J. (1990) Handbook of Sample Size Guidelines for Clinical Trials. CRC Press, Boca Raton, FL.
Lachin, J. M. (1981) Introduction to sample size determination and power analysis for clinical trials. Control Clin. Trials 2, 93–113.
Zar, J. H. (1996) Biostatistical Analysis, Prentice Hall, Upper Saddle River, NJ.
Dawson-Saunders, B. and Trapp, R. G. (1994) Basic and Clinical Biostatistics. Appleton & Lange, Norwalk, CT.
Meinart, C. L. (1986) Clinical Trials: Design, Conduct, and Analysis. Oxford University Press, New York.
Friedman, L. M., Furberg, C., and Demets, D. L. (1996) Fundamentals of Clinical Trials, 3rd ed. Mosby, St. Louis, MO.
Graybill, F. A. (1976) Theory and Application of the Linear Model. Duxbury Press, North Scituate, MA.
Current Index to Statistics, Editors: Michael Wichura, Klaus Hinkelmann, http://www.statindex.org/
O’Brien, R. G. and Muller, K. E. (1993) Unified power analysis for t-tests through multivariate hypotheses, in Applied Analysis of Variance in the Behavioral Sciences (Edwards, L. K., ed.). Marcel Dekker, New York, pp. 297–344.
Odeh, R. E. and Fox, M. (1991) Sample Size Choice, 2nd ed. Marcel Dekker, New York.
Schoenfeld, D. A. and Richter, J. R. (1982) Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 38, 163–170.
Chow, S.-C. and Liu, J. (2000) Design and Analysis Bioavailability and Bioequivalence Studies, 2nd ed. Marcel Dekker, New York, p. 139.
Goodwin, S. N. and Berlin, J. A. (1994) The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann. Intern. Med. 121, 202.
Winer, B. J. and Michels, K. M. (1991) Statistical Principles in Experimental Design, 3rd ed. McGraw-Hill. New York, pp. 405–416.
Sham, P. (1998) Statistics in Human Genetics. Arnold, London, p. 21.
Lin, L. I.-K. (1989) A concordance correlation coefficient to evaluate reproduc-ibility. Biometrics 45, 255–268.
Lin, L. I.-K. (1992) Assay validation using the concordance correlation coefficient. Biometrics 48, 599–604.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Goldsmith, L.J. (2002). Power and Sample Size Considerations in Molecular Biology. In: Looney, S.W. (eds) Biostatistical Methods. Methods in Molecular Biology™, vol 184. Humana Press. https://doi.org/10.1385/1-59259-242-2:111
Download citation
DOI: https://doi.org/10.1385/1-59259-242-2:111
Publisher Name: Humana Press
Print ISBN: 978-0-89603-951-3
Online ISBN: 978-1-59259-242-5
eBook Packages: Springer Protocols